cBioPortal is a widely used platform designed to simplify the exploration of complex cancer genomic data. It brings together large-scale datasets—covering mutations, copy number alterations, gene expression, and clinical annotations—and presents them through an intuitive, interactive interface. Since its launch, it khas become a cornerstone of cancer research, helping translate raw genomic data into meaningful biological insights.
cBioPortal Is Now Available at EGA
At the European Genome-phenome Archive (EGA), we host controlled-access genomic and phenoclinical datasets. By integrating cBioPortal within EGA, researchers could explore cancer datasets (once access has been granted by data owners) through the powerful and user-friendly cBioportal interface.
We believe this marks an important step forward for the cancer research community, with several key benefits:
- Faster Insights
Researchers can quickly visualize and explore datasets through the cBioPortal interface before downloading and analyzing complex raw data. This provides an immediate overview, saving time and enabling more informed decisions about which datasets to pursue.
- Broader Accessibility
Working with complex genomic data often requires advanced computational and bioinformatic expertise. This integration lowers the technical barrier, allowing a wider range of scientists to engage with high-value datasets and, for example, accelerate hypothesis generation.
- Enhanced Data Integration
cBioPortal enables the seamless combination of genomic and clinical data, as well as the comparison and exploration of multiple datasets within a single platform. This promotes more comprehensive analyses and supports deeper biological insights.
The arrival of cBioPortal at EGA brings together powerful visualization and controlled data access, making it easier than ever for researchers to transform complex cancer genomics data into actionable knowledge.
Data submitters: Would you like to make your cBioPortal data available? See our documentation page.
